搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Rickettsia africae DNA replication and repair protein recF (recF) CSB-YP503810RMN
CSB-EP503810RMN
CSB-BP503810RMN
CSB-MP503810RMN
CSB-EP503810RMN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rickettsia africae UPF0301 protein RAF_ORF0041 (RAF_ORF0041) CSB-YP503811RMN
CSB-EP503811RMN
CSB-BP503811RMN
CSB-MP503811RMN
CSB-EP503811RMN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rickettsia africae Probable tRNA threonylcarbamoyladenosine biosynthesis protein Gcp (gcp) CSB-YP503812RMN
CSB-EP503812RMN
CSB-BP503812RMN
CSB-MP503812RMN
CSB-EP503812RMN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rickettsia africae 30S ribosomal protein S18 (rpsR) CSB-YP503813RMN
CSB-EP503813RMN
CSB-BP503813RMN
CSB-MP503813RMN
CSB-EP503813RMN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rickettsia africae 50S ribosomal protein L9 (rplI) CSB-YP503814RMN
CSB-EP503814RMN
CSB-BP503814RMN
CSB-MP503814RMN
CSB-EP503814RMN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rickettsia africae tRNA (Ile)-lysidine synthase CSB-YP503815RMN
CSB-EP503815RMN
CSB-BP503815RMN
CSB-MP503815RMN
CSB-EP503815RMN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rickettsia africae Prolipoprotein diacylglyceryl transferase (lgt), partial CSB-YP503816RMN1
CSB-EP503816RMN1
CSB-BP503816RMN1
CSB-MP503816RMN1
CSB-EP503816RMN1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rickettsia africae Membrane protein insertase YidC (yidC), partial CSB-YP503817RMN1
CSB-EP503817RMN1
CSB-BP503817RMN1
CSB-MP503817RMN1
CSB-EP503817RMN1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rickettsia africae tRNA uridine 5-carboxymethylaminomethyl modification enzyme MnmG (mnmG), partial CSB-YP503818RMN
CSB-EP503818RMN
CSB-BP503818RMN
CSB-MP503818RMN
CSB-EP503818RMN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rickettsia africae Ribosomal RNA small subunit methyltransferase G (rsmG) CSB-YP503819RMN
CSB-EP503819RMN
CSB-BP503819RMN
CSB-MP503819RMN
CSB-EP503819RMN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rickettsia africae 2-dehydro-3-deoxyphosphooctonate aldolase (kdsA) CSB-YP503820RMN
CSB-EP503820RMN
CSB-BP503820RMN
CSB-MP503820RMN
CSB-EP503820RMN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rickettsia africae Deoxyguanosinetriphosphate triphosphohydrolase-like protein (RAF_ORF0088) CSB-YP503821RMN
CSB-EP503821RMN
CSB-BP503821RMN
CSB-MP503821RMN
CSB-EP503821RMN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rickettsia africae Arginine--tRNA ligase (argS), partial CSB-YP503822RMN
CSB-EP503822RMN
CSB-BP503822RMN
CSB-MP503822RMN
CSB-EP503822RMN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rickettsia africae Deoxycytidine triphosphate deaminase (dcd) CSB-YP503823RMN
CSB-EP503823RMN
CSB-BP503823RMN
CSB-MP503823RMN
CSB-EP503823RMN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rickettsia africae Protein-export protein secB (secB) CSB-YP503824RMN
CSB-EP503824RMN
CSB-BP503824RMN
CSB-MP503824RMN
CSB-EP503824RMN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rickettsia africae NADPH-dependent 7-cyano-7-deazaguanine reductase (queF) CSB-YP503825RMN
CSB-EP503825RMN
CSB-BP503825RMN
CSB-MP503825RMN
CSB-EP503825RMN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rickettsia africae Cysteine--tRNA ligase (cysS) CSB-YP503826RMN
CSB-EP503826RMN
CSB-BP503826RMN
CSB-MP503826RMN
CSB-EP503826RMN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rickettsia africae 30S ribosomal protein S2 (rpsB) CSB-YP503827RMN
CSB-EP503827RMN
CSB-BP503827RMN
CSB-MP503827RMN
CSB-EP503827RMN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rickettsia africae Alanine racemase (alr) CSB-YP503828RMN
CSB-EP503828RMN
CSB-BP503828RMN
CSB-MP503828RMN
CSB-EP503828RMN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rickettsia africae 50S ribosomal protein L28 (rpmB) CSB-YP503829RMN
CSB-EP503829RMN
CSB-BP503829RMN
CSB-MP503829RMN
CSB-EP503829RMN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過(guò)多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開(kāi)發(fā)過(guò)程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開(kāi)發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過(guò)多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過(guò)程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見(jiàn)問(wèn)題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問(wèn),涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>